• This record comes from PubMed

Different Grey Matter Microstructural Patterns in Cognitively Healthy Versus Typical Ageing Healthy Versus Typical Brain Ageing

. 2025 Jan ; 38 (1) : e5305.

Language English Country Great Britain, England Media print

Document type Journal Article, Comparative Study

Grant support
CZ.02.01.01/00/22_008/0004643 Brain Dynamics
P41 EB027061 NIBIB NIH HHS - United States
P41 EB027061 NIH HHS - United States
U01 AG052564 NIA NIH HHS - United States
R01 AG055591 NIA NIH HHS - United States
R01 AG055591 NIH HHS - United States
MH CZ-DRO-VFN64165 General University Hospital in Prague
Charles University, Czech Republic
U01AG052564 NIH HHS - United States

Ageing is a complex phenomenon affecting a wide range of coexisting biological processes. The homogeneity of the studied population is an essential parameter for valid interpretations of outcomes. The presented study capitalises on the MRI data available in the Human Connectome Project-Aging (HCP-A) and, within individuals over 55 years of age who passed the HCP-A section criteria, compares a subgroup of 37 apparently neurocognitively healthy individuals selected based on stringent criteria with 37 age and sex-matched individuals still representative of typical ageing but who did not pass the stringent definition of neurocognitively healthy. Specifically, structural scans, diffusion weighted imaging and T1w/T2w ratio were utilised. Furthermore, data of 26 HCP-A participants older than 90 years as notional 'super-agers' were analysed. The relationship of age and several microstructural MRI metrics (T1w/T2w ratio, mean diffusivity, intracellular volume fraction and free water volume fraction) differed significantly between typical and healthy ageing cohort in areas highly relevant for ageing such as hippocampus, prefrontal and temporal cortex and cerebellum. However, the trajectories of the healthy ageing population did not show substantially better overlap with the findings in people older than 90 than those of the typical population. Therefore, caution must be exercised in the choice of adequate study group characteristics relevant for respective ageing-related hypotheses. Contrary to typical ageing group, the healthy ageing cohort may show generally stable levels of several MRI metrics of interest.

Erratum In

PubMed

See more in PubMed

Martin C. R., Preedy V. R., and Rajendram R., Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet (San Diego, CA: Academic Press, 2021).

Costantino S., Paneni F., and Cosentino F., “Ageing, Metabolism and Cardiovascular Disease,” Journal of Physiology 594, no. 8 (2016): 2061–2073. PubMed PMC

de Roos A., van der Grond J., Mitchell G., and Westenberg J., “Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular‐Driven Disease?,” Circulation 135, no. 22 (2017): 2178–2195. PubMed PMC

Carnevale L., D'Angelosante V., Landolfi A., et al., “Brain MRI Fiber‐Tracking Reveals White Matter Alterations in Hypertensive Patients Without Damage at Conventional Neuroimaging,” Cardiovascular Research 114, no. 11 (2018): 1536–1546. PubMed

Raz N., Rodrigue K. M., and Acker J. D., “Hypertension and the Brain: Vulnerability of the Prefrontal Regions and Executive Functions,” Behavioral Neuroscience 117, no. 6 (2003): 1169–1180. PubMed

Salthouse T. A., “Selective Review of Cognitive Aging,” Journal of the International Neuropsychological Society 16, no. 5 (2010): 754–760. PubMed PMC

MacDonald M. E. and Pike G. B., “MRI of Healthy Brain Aging: A Review,” NMR in Biomedicine 34, no. 9 (2021): e4564. PubMed

Kamiya K., Hori M., and Aoki S., “NODDI in Clinical Research,” Journal of Neuroscience Methods 346 (2020): 108908. PubMed

Filip P., Kokošová V., Valenta Z., et al., “Utility of Quantitative MRI Metrics in Brain Ageing Research,” Frontiers in Aging Neuroscience 15 (2023): 15. PubMed PMC

Bookheimer S. Y., Salat D. H., Terpstra M., et al., “The Lifespan Human Connectome Project in Aging: An Overview,” NeuroImage 185 (2019): 335–348. PubMed PMC

Harms M. P., Somerville L. H., Ances B. M., et al., “Extending the Human Connectome Project Across Ages: Imaging Protocols for the Lifespan Development and Aging Projects,” NeuroImage 183 (2018): 972–984. PubMed PMC

Beaulieu C., “The Biological Basis of Diffusion Anisotropy,” in Diffusion MRI (San Diego, CA: Elsevier, 2014): 155–183.

Christensen K. J., Moye J., Armson R. R., and Kern T. M., “Health Screening and Random Recruitment for Cognitive Aging Research,” Psychology and Aging 7, no. 2 (1992): 204–208. PubMed PMC

McCarten J. R., “Clinical Evaluation of Early Cognitive Symptoms,” Clinics in Geriatric Medicine 29, no. 4 (2013): 791–807. PubMed

Chételat G., La Joie R., Villain N., et al., “Amyloid Imaging in Cognitively Normal Individuals, At‐Risk Populations and Preclinical Alzheimer's Disease,” NeuroImage Clinical 2 (2013): 356–365. PubMed PMC

Ho D., Imai K., King G., and Stuart E. A., “MatchIt: Nonparametric Preprocessing for Parametric Causal Inference,” Journal of Statistical Software 42 (2011): 1–28.

Glasser M. F., Sotiropoulos S. N., Wilson J. A., et al., “The Minimal Preprocessing Pipelines for the Human Connectome Project,” NeuroImage 80 (2013): 105–124. PubMed PMC

Glasser M. F., Coalson T. S., Robinson E. C., et al., “A Multi‐Modal Parcellation of Human Cerebral Cortex,” Nature 536, no. 7615 (2016): 171–178. PubMed PMC

Robinson E. C., Jbabdi S., Glasser M. F., et al., “MSM: A New Flexible Framework for Multimodal Surface Matching,” NeuroImage 100 (2014): 414–426. PubMed PMC

Ji J. L., Spronk M., Kulkarni K., Repovš G., Anticevic A., and Cole M. W., “Mapping the Human Brain's Cortical‐Subcortical Functional Network Organization,” NeuroImage 15, no. 185 (2019): 35–57. PubMed PMC

Winkler A. M., Ridgway G. R., Webster M. A., Smith S. M., and Nichols T. E., “Permutation Inference for the General Linear Model,” NeuroImage 92 (2014): 381–397. PubMed PMC

Benjamini Y. and Hochberg Y., “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing,” Journal of the Royal Statistical Society: Series B: Methodological 57, no. 1 (1995): 289–300.

Oschwald J., Guye S., Liem F., et al., “Brain Structure and Cognitive Ability in Healthy Aging: A Review on Longitudinal Correlated Change,” Reviews in the Neurosciences 31, no. 1 (2020): 1–57. PubMed PMC

Del Brutto O. H., Mera R. M., Zambrano M., Soriano F., and Lama J., “Global Cortical Atrophy (GCA) Associates With Worse Performance in the Montreal Cognitive Assessment (MoCA). A Population‐Based Study in Community‐Dwelling Elders Living in Rural Ecuador,” Archives of Gerontology and Geriatrics 60, no. 1 (2015): 206–209. PubMed

Mariani E., Monastero R., and Mecocci P., “Mild Cognitive Impairment: A Systematic Review,” Journal of Alzheimer's Disease 12, no. 1 (2007): 23–35. PubMed

Petersen R. C., Wiste H. J., Weigand S. D., et al., “ nia‐aa Alzheimer's Disease Framework: Clinical Characterization of Stages,” Annals of Neurology 89, no. 6 (2021): 1145–1156. PubMed PMC

Möller H. E., Bossoni L., Connor J. R., et al., “Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology,” Trends in Neurosciences 42, no. 6 (2019): 384–401. PubMed

Palombo M., Ianus A., Guerreri M., et al., “SANDI: A Compartment‐Based Model for Non‐Invasive Apparent Soma and Neurite Imaging by Diffusion MRI,” NeuroImage 215 (2020): 116835. PubMed PMC

Stüber C., Morawski M., Schäfer A., et al., “Myelin and Iron Concentration in the Human Brain: A Quantitative Study of MRI Contrast,” NeuroImage 93 (2014): 95–106. PubMed

Glasser M. F. and Van Essen D. C., “Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1‐ and T2‐Weighted MRI,” Journal of Neuroscience: The Official Journal of the Society for Neuroscience 31, no. 32 (2011): 11597–11616. PubMed PMC

Filip P., Svatkova A., Carpenter A. F., et al., “Rotating Frame MRI Relaxations as Markers of Diffuse White Matter Abnormalities in Multiple Sclerosis,” NeuroImage: Clinical 26 (2020): 102234. PubMed PMC

Potvin O., Duchesne S., and Dieumegarde L., “T1w/T2w MRI Ratio Brain Signature Across Degenerative Syndromes and Their Cognitive Impairment Continuum and Mixed Presentations,” Alzheimer's & Dementia 19, no. S16 (2023): e073778.

Sui Y. V., Masurkar A. V., Rusinek H., Reisberg B., and Lazar M., “Cortical Myelin Profile Variations in Healthy Aging Brain: A T1w/T2w Ratio Study,” NeuroImage 264 (2022): 119743. PubMed PMC

Cox S. R., Ritchie S. J., Tucker‐Drob E. M., et al., “Ageing and Brain White Matter Structure in 3,513 UK Biobank Participants,” Nature Communications 7, no. 1 (2016): 13629. PubMed PMC

Slater D. A., Melie‐Garcia L., Preisig M., Kherif F., Lutti A., and Draganski B., “Evolution of White Matter Tract Microstructure Across the Life Span,” Human Brain Mapping 40, no. 7 (2019): 2252–2268. PubMed PMC

Filip P., Gallea C., Lehéricy S., Lungu O., and Bareš M., “Neural Scaffolding as the Foundation for Stable Performance of Aging Cerebellum,” Cerebellum 18, no. 3 (2019): 500–510, 10.1007/s12311-019-01015-7. PubMed DOI

Filip P. and Bareš M., “Cerebellum—Aging of the Neuronal Machine,” in Factors Affecting Neurological Aging (San Diego, CA: Elsevier, 2021): 281–288.

Freitas S., Simões M. R., Alves L., and Santana I., “Montreal Cognitive Assessment: Influence of Sociodemographic and Health Variables,” Archives of Clinical Neuropsychology 27, no. 2 (2012): 165–175. PubMed

Weiskopf N., Edwards L. J., Helms G., Mohammadi S., and Kirilina E., “Quantitative Magnetic Resonance Imaging of Brain Anatomy and in Vivo Histology,” Nature Reviews Physics 3, no. 8 (2021): 570–588.

Farrell M. E., Jiang S., Schultz A. P., et al., “Defining the Lowest Threshold for Amyloid‐PET to Predict Future Cognitive Decline and Amyloid Accumulation,” Neurology 96, no. 4 (2021): e619–31. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...